Nillar (Esomeprazole Magnesium)

Esomeprazole magnesium, the active ingredient in Nillar, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to manage acid‑related gastrointestinal conditions. GNH USA supplies Nillar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole magnesium is a proton pump inhibitor indicated for several acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal irritation. - Erosive oesophagitis: reduces acid exposure to allow mucosal recovery. - NSAID‑induced gastric ulcer: protects the gastric lining by lowering acid secretion. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Helicobacter pylori eradication (as part of combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic environment.

Common side effects are generally mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring intermittently. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low serum magnesium: muscle cramps or irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Before initiating therapy, consider the following precautions. - Renal function assessment: adjust use in severe renal impairment. - Hepatic impairment: use with caution in patients with liver disease. - Magnesium monitoring: check levels during prolonged treatment. - Long‑term use: evaluate risk‑benefit for chronic therapy. - Drug‑interaction review: assess concomitant medications that may affect acid levels. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Esomeprazole magnesium can alter the absorption or metabolism of several drugs.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal efficacy due to decreased absorption. - Atazanavir: markedly lowered antiviral concentrations. - Clopidogrel: diminished antiplatelet activation.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels requiring dose adjustment. - Methotrexate: potential for elevated toxicity, especially at high doses. - HIV protease inhibitors (e.g., ritonavir): altered plasma concentrations. - Phenytoin: possible reduction in antiepileptic effect. - Fluconazole: may increase esomeprazole exposure.